Background
Infection of the structures in the mediastinum
The mediastinum refers to the space between the lungs which contains the heart, thymus, esophagus, and trachea
Confusing nomenclature, and includes mediastinal infections caused by extension of a cervical infection (necrotizing mediastinitis or descending mediastinitis) and mediastinal infection after sternotomy (sternal infection or deep sternal wound infection)
CDC Definition
One of the following:
Organisms cultured from mediastinal tissue or fluid
Gross anatomical or histopathologic evidence of mediastinitis
Fever, chest pain, or sternal instability
Plus one of the following:
Purulence from the mediastinal area
Mediastinal widening on imaging
Microbiology
Post-cardiac surgery: often mixed
Esophageal rupture: polymicrobial, with oropharyngeal and gastrointestinal flora including anaerobes
Can also occur from contiguous extension of pneumonia , pancreatitis , subphrenic abscess , or epidural abscess , with the microbiology determined by the source of infection
Epidemiology
Post-surgical deep sternal wound infections occur after about 1% of cardiac surgeries
Incidence increases with the complexity of the operation, and is highest with CABG = valve replacement or aortic surgery
Risk increases with BMI, diabetes, and number of platelet transfusions
Clinical Manfestation
Usually presents within 30 days of surgery
Fever, chest pain, drainage from surgical site
See CDC definition, above
Prognosis
For deep sternal wound infections after cardiac surgery
Mortality is about 15% in the short term, but is also higher than those without infection in the years following surgery
Mortality is higher when Gram-negatives are isolated
Investigations
CT chest can show evidence, including sternal wire displacement, sternal disruption, free gas, or fluid collections
Surgical exploration, with fluid sent for culture
Management
In general, surgical exploration with debridement should always be performed as quickly as possible
Empiric antibiotics should be broad, including coverage for MRSA and resistant Gram-negatives
Antimicrobials directed by culture results
Duration of therapy unclear but depends on adequacy of source control, presence of sternal osteitis, and presence of metal or other foreign bodies
Probably somewhere between 3 and 12 weeks
Following sternal resection and pectoral flap: maybe 2 to 3 weeks
After debridement without resection, or with residual bone infection: probably 4 to 6 weeks